1 May 2025 false No description of principal activity Taxfiler 2024.6 11930365 business:PrivateLimitedCompanyLtd 2025-05-01 2026-04-30 11930365 2025-04-30 11930365 2025-05-01 2026-04-30 11930365 business:AuditExempt-NoAccountantsReport 2025-05-01 2026-04-30 11930365 business:FilletedAccounts 2025-05-01 2026-04-30 11930365 2026-04-30 11930365 business:Director3 2025-05-01 2026-04-30 11930365 business:RegisteredOffice 2025-05-01 2026-04-30 11930365 2025-04-30 11930365 core:WithinOneYear 2026-04-30 11930365 core:WithinOneYear 2025-04-30 11930365 core:ShareCapital core:PreviouslyStatedAmount 2026-04-30 11930365 core:ShareCapital core:PreviouslyStatedAmount 2025-04-30 11930365 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2026-04-30 11930365 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-04-30 11930365 core:PreviouslyStatedAmount 2026-04-30 11930365 core:PreviouslyStatedAmount 2025-04-30 11930365 business:SmallEntities 2025-05-01 2026-04-30 11930365 countries:EnglandWales 2025-05-01 2026-04-30 11930365 core:ComputerEquipment 2025-05-01 2026-04-30 11930365 core:ComputerEquipment 2025-04-30 11930365 core:ComputerEquipment 2026-04-30 11930365 2024-05-01 2025-04-30 iso4217:GBP xbrli:pure
Company Registration No. 11930365 (England and Wales)
Sterling Pharma Limited Unaudited accounts for the year ended 30 April 2026
Sterling Pharma Limited Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
Sterling Pharma Limited Company Information for the year ended 30 April 2026
Director
Mohammed Adam Issat
Company Number
11930365 (England and Wales)
Registered Office
195-197 OTLEY ROAD BRADFORD WEST YORKSHIRE BD3 0JF UNITED KINGDOM
- 3 -
Sterling Pharma Limited Statement of financial position as at 30 April 2026
2026
2025
Notes
£
£
Fixed assets
Tangible assets
4
795
1,293
Current assets
Inventories
21,272
36,582
Debtors
5
4,102
16,989
Cash at bank and in hand
17,961
15,595
43,335
69,166
Creditors: amounts falling due within one year
6
(42,311)
(91,208)
Net current assets/(liabilities)
1,024
(22,042)
Net assets/(liabilities)
1,819
(20,749)
Capital and reserves
Called up share capital
100
100
Profit and loss account
1,719
(20,849)
Shareholders' funds
1,819
(20,749)
For the year ending 30 April 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 25 June 2026 and were signed on its behalf by
Mohammed Adam Issat Director Company Registration No. 11930365
- 4 -
Sterling Pharma Limited Notes to the Accounts for the year ended 30 April 2026
1
Statutory information
Sterling Pharma Limited is a private company, limited by shares, registered in England and Wales, registration number 11930365. The registered office is 195-197 OTLEY ROAD, BRADFORD, WEST YORKSHIRE, BD3 0JF, UNITED KINGDOM.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Computer equipment
20% straight line
4
Tangible fixed assets
Computer equipment
£
Cost or valuation
At cost
At 1 May 2025
4,644
At 30 April 2026
4,644
Depreciation
At 1 May 2025
3,351
Charge for the year
498
At 30 April 2026
3,849
Net book value
At 30 April 2026
795
At 30 April 2025
1,293
5
Debtors
2026
2025
£
£
Amounts falling due within one year
Trade debtors
4,102
5,878
Other debtors
-
11,111
4,102
16,989
- 5 -
Sterling Pharma Limited Notes to the Accounts for the year ended 30 April 2026
6
Creditors: amounts falling due within one year
2026
2025
£
£
VAT
5,348
57,775
Trade creditors
65
-
Taxes and social security
3,002
158
Other creditors
31,450
32,000
Loans from directors
421
-
Accruals
2,025
1,275
42,311
91,208
7
Average number of employees
During the year the average number of employees was 1 (2025: 1).
- 6 -